Compass Therapeutics, Inc. (CMPX)
USD 1.42
(-7.19%)
USD 1.42
(-7.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.89 Million | 1.9 Million | 1.62 Million | 2.4 Million | 2.12 Million | 1.92 Million |
| Gross Profit | -1.89 Million | -1.9 Million | -1.62 Million | -2.4 Million | -2.12 Million | -1.92 Million |
| Operating Expenses | 48.47 Million | 41.65 Million | 31.26 Million | 27.81 Million | 34.05 Million | 38.31 Million |
| Selling, General and Administrative Expenses | 11.05 Million | 11.65 Million | 10.92 Million | 12.9 Million | 11.6 Million | 11.21 Million |
| Research and Development Expenses | 37.42 Million | 29.99 Million | 20.33 Million | 14.9 Million | 22.44 Million | 27.09 Million |
| Other Expenses | - | - | 50.61 Million | - | - | - |
| Cost and Expenses | 50.36 Million | 41.65 Million | 31.26 Million | 27.81 Million | 34.05 Million | 38.31 Million |
| Operating Income | -50.36 Million | -41.65 Million | -81.88 Million | -27.81 Million | -34.05 Million | -38.31 Million |
| Interest Expense | - | 2.36 Million | 370 Thousand | 908 Thousand | 1.22 Million | 767 Thousand |
| Income Tax Expense | - | -2.43 Million | 370 Thousand | 32 Thousand | 91 Thousand | 103 Thousand |
| Earnings before Tax | -42.49 Million | -39.22 Million | -82.18 Million | -29.46 Million | -34.65 Million | -38.18 Million |
| Net Income | -42.49 Million | -36.79 Million | -82.55 Million | -29.5 Million | -34.74 Million | -38.28 Million |
| Earnings Per Share Basic | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
| Earnings Per Share Diluted | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
| Weighted Average Shares Outstanding | 127.02 Million | 105.18 Million | 62.87 Million | 30.77 Million | 52.11 Million | 52.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.02 Million | 105.18 Million | 62.87 Million | 30.77 Million | 52.11 Million | 52.11 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -48.47 Million | -37.39 Million | -29.61 Million | -25.32 Million | -31.18 Million | -35.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2.84 Million | - | - | - |
| Cost of Revenue | 463 Thousand | 1.89 Million | 468 Thousand | 466 Thousand | 475 Thousand | 481 Thousand |
| Gross Profit | -463 Thousand | -1.89 Million | 2.37 Million | -466 Thousand | -475 Thousand | -481 Thousand |
| Operating Expenses | 12.3 Million | 48.47 Million | 14.92 Million | 11.92 Million | 13.33 Million | 9.71 Million |
| Selling, General and Administrative Expenses | 2.93 Million | - | 2.66 Million | 3.09 Million | 3.11 Million | 3.07 Million |
| Research and Development Expenses | 9.36 Million | - | 12.26 Million | 8.83 Million | 10.22 Million | 6.63 Million |
| Other Expenses | 1.98 Million | - | -1.87 Million | - | - | 1.87 Million |
| Cost and Expenses | 12.77 Million | 50.36 Million | 15.39 Million | 11.92 Million | 13.33 Million | 9.71 Million |
| Operating Income | -12.77 Million | -50.36 Million | -15.39 Million | -11.92 Million | -13.33 Million | -9.71 Million |
| Interest Expense | - | - | 1.87 Million | - | - | -1.87 Million |
| Income Tax Expense | 419.72 Thousand | - | 1.87 Million | 505.58 Thousand | 352.91 Thousand | -1.87 Million |
| Earnings before Tax | -10.78 Million | -42.49 Million | -13.41 Million | -9.96 Million | -11.27 Million | -7.83 Million |
| Net Income | -10.78 Million | -42.49 Million | -13.41 Million | -9.96 Million | -11.27 Million | -5.96 Million |
| Earnings Per Share Basic | -0.08 | - | -0.11 | -0.08 | -0.09 | -0.05 |
| Earnings Per Share Diluted | -0.08 | - | -0.11 | -0.08 | -0.09 | -0.05 |
| Weighted Average Shares Outstanding | 136.6 Million | 127.02 Million | 127.66 Million | 127.42 Million | 126.72 Million | 126.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 136.6 Million | 127.02 Million | 127.66 Million | 127.42 Million | 126.72 Million | 126.37 Million |
| Gross Margin | - | - | 0.84 | - | - | - |
| EBIT Margin | - | - | -5.25 | - | - | - |
| Profit Margin | - | - | -4.72 | - | - | - |
| EBITDA | -12.3 Million | - | -14.92 Million | -11.46 Million | -12.86 Million | -9.23 Million |
| Earnings Before Tax Margin | - | - | -5.41 | - | - | - |
MEITF
AMBOAGRI
RRL
PNL
XSVT
HFEL